Sharekhan

Experience the insightful 3R Podcast! Tune in now to gain valuable long-term views from Sharekhan's experts on #Aurobindopharma & #hindustanaeronautics Disclaimer : https://t.co/52SBqessf3 #Sharekhan #Podcast https://t.co/Flx0zHJNej #Aurobindopharma #hindustanaeronautics #Sharekhan #Podcast

Posted On: 15 Nov 2023

#SharekhanResearch retains Buy rating on #Aurobindo (PT Rs 875), Weak #Q3FY22; US price erosion likely to stabilise… https://t.co/Hw1ifoJClZ #SharekhanResearch #Aurobindo #Q3FY22

Posted On: 11 Feb 2022

#SharekhanFNA #SharekhanResearch retains Buy rating on #Aurobindo (PT Rs 875) #Q2FY22 was weak qtr; sustained headw… https://t.co/HXdVdjEtPc #SharekhanFNA #SharekhanResearch #Aurobindo #Q2FY22

Posted On: 10 Nov 2021

#SharekhanFNA #SharekhanResearch retains Buy rating on #Aurobindo (PT Rs1185) #Q4FY21 was a weak qtr; US & Europe w… https://t.co/pGlvcfG2s3 #SharekhanFNA #SharekhanResearch #Aurobindo #Q4FY21

Posted On: 01 Jun 2021

#SharekhanFNA #SharekhanResearch retains Buy on #Aurobindo(PT Rs 1100) sturdy product pipeline, strong growth in In… https://t.co/azstQo6txO #SharekhanFNA #SharekhanResearch #Aurobindo

Posted On: 31 Mar 2021

#SharekhanFNA #AurobindoPharma signs exclusive agreement with US based Covaxx to develop & commercialize #Covaxx’s… https://t.co/zswXz9k1RP #SharekhanFNA #AurobindoPharma #Covaxx

Posted On: 24 Dec 2020

#SharekhanFNA #SharekhanResarch retains Buy recommendation on #AurobindoPharma, PT Rs1024; US business constituting… https://t.co/Xsn2clnMvh #SharekhanFNA #SharekhanResarch #AurobindoPharma

Posted On: 18 Dec 2020

#SharekhanFNA #SharekhanResarch retains Buy recommendation on #AurobindoPharma(PT Rs1024)#Q2FY21 was strong qtr; I… https://t.co/rw7oCq7CLp #SharekhanFNA #SharekhanResarch #AurobindoPharma #Q2FY21

Posted On: 13 Nov 2020

#SharekhanFNA #SharekhanResearch retains Hold recommendation on #AurobindoPharma (PT Rs 500) Regulatory hurdles at… https://t.co/d5iLZ6MjBo #SharekhanFNA #SharekhanResearch #AurobindoPharma

Posted On: 14 Nov 2019